Uterine Cancer Symptoms - Causes, Treatment & When to See a Doctor

```html

What is Uterine Cancer Symptoms?

Uterine cancer, also known as endometrial cancer, originates in the lining (the endometrium) of the uterus. While the disease itself is defined by abnormal cells growing uncontrollably, the term “uterine cancer symptoms” refers to the clinical signs and sensations that a person may notice before or after the cancer is diagnosed. Recognizing these symptoms early can lead to prompt evaluation, earlier-stage diagnosis, and higher chances of successful treatment.

According to the American Cancer Society, uterine cancer is the fourth most common cancer among women in the United States, and most cases are discovered because of symptoms rather than routine screening. The most frequently reported symptom is abnormal vaginal bleeding, but other signs can be subtle and vary with the cancer’s stage.

Common Causes

Uterine cancer does not arise from a single cause. Instead, a combination of hormonal, genetic, and lifestyle factors creates an environment where endometrial cells can become malignant. Below are the most widely recognized risk contributors (often referred to as “causes” in lay language):

• Excess estrogen exposure without adequate progesterone (e.g., obesity, early menarche, late menopause).
• Obesity – adipose tissue converts androgens to estrogen, increasing endometrial proliferation.
• Polycystic ovary syndrome (PCOS) – chronic anovulation leads to unopposed estrogen.
• Tamoxifen therapy for breast cancer, which acts as an estrogen agonist in the uterus.
• Family history of Lynch syndrome (hereditary non‑polyposis colorectal cancer) – mutations in DNA‑repair genes (MLH1, MSH2, MSH6, PMS2).
• Prior radiation therapy to the pelvic area.
• Diabetes – often co‑exists with obesity and insulin resistance, both of which may promote cancer growth.
• Nulliparity or never having been pregnant – pregnancy provides a protective hormonal milieu.
• Early onset of menstruation or late onset of menopause – longer lifetime exposure to estrogen.
• Use of certain fertility drugs (e.g., clomiphene) that stimulate estrogen production.

Associated Symptoms

When the endometrium begins to grow abnormally, a cluster of symptoms often appears. Not every woman will have all of these, and some may experience only one.

• Abnormal uterine bleeding – spotting, heavy periods, or bleeding between periods; post‑menopausal bleeding is especially concerning.
• Painful intercourse (dyspareunia) – especially if the tumor involves the cervical or vaginal tissue.
• Pelvic pain or pressure – a vague ache or a feeling of fullness in the lower abdomen.
• Unexplained weight loss – may indicate advanced disease.
• Changes in urinary habits – urgency or frequency if the tumor presses on the bladder.
• Fatigue – a common systemic symptom of many cancers.
• Back pain – can result from spread to nearby structures.
• Enlarged uterus on physical exam – often detected by a clinician during a pelvic exam.

When to See a Doctor

Because early uterine cancer frequently presents with bleeding, any unexpected vaginal bleeding should prompt a medical evaluation. Below is a practical checklist to help you decide when to make an appointment:

• Any vaginal bleeding after menopause.
• Bleeding between periods or after intercourse.
• A sudden change in menstrual flow (heavier, longer, or irregular).
• Persistent pelvic pain or pressure lasting more than a few weeks.
• Unexplained weight loss, fatigue, or loss of appetite.
• History of risk factors (obesity, PCOS, Lynch syndrome, tamoxifen use) combined with any of the above symptoms.

If you experience any of these, schedule a visit with your primary‑care physician or a gynecologist promptly. Early assessment dramatically improves treatment outcomes.

Diagnosis

Diagnosing uterine (endometrial) cancer involves a step‑wise approach to confirm the presence of cancer, determine its type, and stage its spread.

1. Medical History & Physical Exam

The clinician will ask detailed questions about bleeding patterns, pain, hormonal history, and risk factors, followed by a pelvic exam to feel for uterine enlargement or masses.

2. Endometrial Sampling

• Transvaginal ultrasound (TVUS) – assesses endometrial thickness; a thickness >4‑5 mm in post‑menopausal women is suspicious.
• Endometrial biopsy – a thin pipelle device obtains tissue from the uterine lining. If cancer is present, cells will show atypia under a pathologist’s microscope.
• Dilation & curettage (D&C) – performed if biopsy is non‑diagnostic or if a larger tissue sample is needed.

3. Imaging for Staging

• CT scan of the abdomen/pelvis – evaluates spread to lymph nodes or distant organs.
• MRI – offers detailed soft‑tissue contrast, useful for assessing myometrial invasion.
• PET‑CT – can detect metabolically active metastatic lesions.

4. Pathology & Molecular Testing

After tissue is obtained, pathologists determine the histologic subtype (most commonly endometrioid adenocarcinoma) and grade (1‑3). Molecular profiling (e.g., POLE mutation, p53 status) is increasingly used to guide targeted therapies, per the NCCN Guidelines.

Treatment Options

Treatment is individualized based on cancer stage, histology, patient health, and fertility desires. Below are the main modalities, with brief home‑care suggestions to support recovery.

Surgical Management

• Total hysterectomy – removal of the uterus and cervix.
• Bilateral salpingo‑oophorectomy – removal of both ovaries and fallopian tubes (often performed concurrently).
• Lymph node assessment – sentinel‑node mapping or systematic pelvic lymphadenectomy to check for spread.
• Fertility‑preserving surgery – for select young women with early, low‑grade disease, hormonal therapy (high‑dose progestin) may be used instead of hysterectomy.

Radiation Therapy

• External beam radiation therapy (EBRT) – delivered to the pelvis post‑operatively for high‑risk features.
• Brachytherapy – internal radiation placed directly in the vaginal cuff, often combined with EBRT.

Systemic (Medical) Therapy

• Chemotherapy – usually a combination of carboplatin and paclitaxel for advanced or recurrent disease.
• Hormonal therapy – progestins (medroxyprogesterone acetate, megestrol) for estrogen‑responsive tumors or patients who cannot undergo surgery.
• Targeted therapy – agents such as pembrolizumab (PD‑1 inhibitor) for tumors with microsatellite instability‑high (MSI‑H) or mismatch repair deficiency (dMMR).
• Immunotherapy – emerging options in clinical trials for certain molecular subtypes.

Supportive & Home‑Based Care

• Maintain a balanced diet rich in fruits, vegetables, whole grains, and lean protein to support healing.
• Engage in gentle activity (e.g., walking) as tolerated to improve circulation and reduce fatigue.
• Practice pelvic floor exercises (Kegels) after surgery to restore muscle tone.
• Utilize a daily diary to track any new or worsening symptoms (bleeding, pain, swelling).
• Seek counseling or support groups (e.g., Cancer Support Community) to address emotional well‑being.

Prevention Tips

While not all cases are preventable, several lifestyle modifications can lower risk:

• Maintain a healthy weight – aim for a BMI < 25 kg/m²; weight loss reduces estrogen production from adipose tissue.
• Stay physically active – at least 150 minutes of moderate aerobic activity per week.
• Manage insulin resistance – diet and, if needed, metformin for diabetic patients.
• Use combined oral contraceptives (estrogen + progestin) for 3‑5 years, as they lower endometrial cancer risk.
• Limit tamoxifen exposure – discuss alternative breast‑cancer treatments with your oncologist if you have a high uterine‑cancer risk.
• Screen for hereditary syndromes – if you have a family history of Lynch syndrome, consider genetic counseling and regular surveillance.
• Regular gynecologic exams – especially if you have risk factors; your provider can assess abnormal bleeding early.

Emergency Warning Signs

Key Take‑aways

Uterine (endometrial) cancer is the most common gynecologic malignancy in developed countries, and its hallmark symptom is abnormal vaginal bleeding. Understanding the risk factors, recognizing the spectrum of associated symptoms, and acting quickly when warning signs appear are essential steps for improving outcomes. Modern care combines surgery, radiation, chemotherapy, hormonal therapy, and targeted agents, while lifestyle choices such as weight management and regular medical follow‑up can reduce the likelihood of disease development.

Always discuss any new or concerning symptoms with a qualified health professional. The information above is intended for educational purposes and does not replace personalized medical advice.

References:

1. American Cancer Society. Endometrial Cancer. 2023. https://www.cancer.org
2. Mayo Clinic. Endometrial cancer – Symptoms and causes. 2022. https://www.mayoclinic.org
3. National Comprehensive Cancer Network. Uterine Neoplasms Guidelines. Version 2.2024. https://www.nccn.org
4. Centers for Disease Control and Prevention. Obesity and Cancer. 2023. https://www.cdc.gov
5. World Health Organization. Hereditary cancer syndromes. 2021. https://www.who.int

```